The road from AKI to CKD: the role of endothelin

Neeraj Dhaun*, David J. Webb

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Abstract / Description of output

The incidence of acute kidney injury (AKI) is increasing. It is now widely accepted that patients surviving an episode of AKI have a significant risk of progression to chronic kidney disease (CKD) and even end-stage renal failure. Zager and colleagues describe the role of endothelin-1 (ET-1) in the progression of AKI to CKD and provide a basis for the potential use of ET receptor antagonists as a therapeutic strategy in AKI.

Original languageEnglish
Pages (from-to)637-638
Number of pages2
JournalKidney International
Issue number4
Publication statusPublished - Oct 2013

Keywords / Materials (for Non-textual outputs)



Dive into the research topics of 'The road from AKI to CKD: the role of endothelin'. Together they form a unique fingerprint.

Cite this